Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

Search Results

Refine Your Search

By Sector

Sort by: Date|Relevance

The EV Battle is Heating Up: Enter “The Tesla Killer”

(IoniX Pro Home Smart Wall Product Rendering via Extreme Vehicle Battery Technologies Corp.) When it comes to the Electric Vehicle (EV) revolution, the future is imminent and those who have adopted this next level lifestyle agree that what they need is power … an...
Stockhouse Editorial | January 11, 2021 |

NantKwest Shares Jump More than 50% Following JP Morgan Healthcare Conference Presentation

Shares of NantKwest Inc. spiked as much as 85% higher in mid-morning trading setting a new 52-week high price after the company reported a series of positive results at the 38th J.P. Morgan Healthcare Conference in San Francisco. The firm reported that complete responses were ...
Streetwise Reports | January 17, 2020 |

Quantum Economics, Negative Interest Rates and Financially Transmitted Diseases

This week the US Federal Reserve announced an emergency rate cut of 0.5% (50bps). It is part of a coordinated effort by central bankers around the world to keep the decade long bull market going a few days longer. Ultra low interest rates and ever depreciating currencie...
Marin Katusa | March 6, 2020 |

Fate Therapeutics Shares Rise 10% as First Person Treated with Its Anti-Cancer Therapy

Shares of Fate Therapeutics traded higher after the firm reported it has treated the first patient in a first-in-human trial of FT596 for patients with B-cell malignancies and chronic lymphocytic leukemia. Clinical-stage biopharmaceutical company Fate Thera...
Streetwise Reports | April 7, 2020 |

PDS Biotech Collaborating with Merck in Phase 2 Cancer Trial

This morning PDS Biotechnology Corp. shares are trading 38% higher after reporting that it will enter into a clinical collaboration with Merck pairing the firm's PDS0101 with KEYTRUDA for patients with recurrent or metastatic head and neck cancer and high-risk HPV16 infection....
Streetwise Reports | October 4, 2019 |

ARway (CSE:ARWY) on the cusp of major deals

Our next company is an AI-powered platform providing people with an augmented reality experience through indoor and outdoor spaces. By utilizing the mini computers that are in most people’s pockets, i.e. phones, ARway leverages the power of these devices t...
Brieanna McCutcheon | May 4, 2023 |

An 'Electrical Storm' of Catalysts Converge to Jump Start Sales of Eguana's Solar-Power ...

An 'Electrical Storm' of Catalysts Converge to Jump Start Sales of Eguana's Solar-Power Storage Solutions The small-cap energy storage firm just signed a global production agreement with industry heavyweight Jabil. The Punch: Eguana Technologies Inc. (EGT:...
Streetwise Reports | September 11, 2019 |

Viva Gold Improves Gold Resource in Nevada

I first wrote about Viva Gold Corp. (VAU:TSX.V; VAUCF:OTCBB) exactly a year ago. The price of gold was about $1300 and the price of a share of Viva was about $0.32. Now gold is $1280 and Viva is still at $0.32. The company has an interesting story and while the price ...
Streetwise Reports | May 27, 2019 |

Gold, the Ultimate Safe Haven Asset. A Looming Nobel Prize?

Yesterday, the Nobel prizes in economics were awarded. Unfortunately, gold has been omitted and got nothing. How unfair! But looking at the Dutch central bank press release, gold would have much higher chances if they were the ones granting the prizes and not the Swedish ...
Arkadiusz Sieron | October 16, 2019 |

INmune Bio Targeting Cancer, Alzheimer's and NASH Simultaneously

We are initiating coverage on INmune Bio Inc. (INMB:NASDAQ) . According to the company, INmune is "Reprogramming the Innate Immune System for the Treatment of Diseases." On the surface, this sounds like a fairly standard biotech tagline, but there's a more here than me...
Streetwise Reports | December 5, 2019 |
1 2 3 4 5